Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Leizorovicz

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Haematologica|August 2, 2007
Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography studyAlain Leizorovicz,
Circulation|December 16, 2004
Preventing venous thromboembolism in medical patientsAlain Leizorovicz, Patrick Mismetti
Current Controlled Trials in Cardiovascular Medicine|May 7, 2002
Pooling, meta-analysis, and the evaluation of drug safetyMichel Lièvre, Michel Cucherat, Alain Leizorovicz
Postgraduate Medical Journal|December 7, 2006
Prevention of venous thromboembolism in medically ill patients: a clinical updateAlexander G G Turpie, Alain Leizorovicz
Angiology|February 21, 2003
The assessment of deep vein thromboses for therapeutic trialsAlain Leizorovicz, Behrouz Kassai, François Becker, et al.
American Heart Journal|February 9, 2002
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol StudyAlain Leizorovicz, Philippe Lechat, Michel Cucherat, et al.
Thrombosis Research|April 12, 2011
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS)Alain Leizorovicz, Virginie Siguret, Dominique Mottier, et al.
Drugs & Aging|October 17, 2003
Aspirin for the prevention of cardiovascular events in the elderlyIsabelle Mahé, Alain Leizorovicz, Charles Caulin, et al.
Blood|September 2, 2011
The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legsPaolo Prandoni, Edoardo Casiglia, Valerie Tikhonoff, et al.
Blood|July 4, 2013
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO studyAlain Leizorovicz, François Becker, Andrea Buchmüller, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Haematologica|August 2, 2007
Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography studyAlain Leizorovicz,
Circulation|December 16, 2004
Preventing venous thromboembolism in medical patientsAlain Leizorovicz, Patrick Mismetti
Current Controlled Trials in Cardiovascular Medicine|May 7, 2002
Pooling, meta-analysis, and the evaluation of drug safetyMichel Lièvre, Michel Cucherat, Alain Leizorovicz
Postgraduate Medical Journal|December 7, 2006
Prevention of venous thromboembolism in medically ill patients: a clinical updateAlexander G G Turpie, Alain Leizorovicz
Angiology|February 21, 2003
The assessment of deep vein thromboses for therapeutic trialsAlain Leizorovicz, Behrouz Kassai, François Becker, et al.
American Heart Journal|February 9, 2002
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol StudyAlain Leizorovicz, Philippe Lechat, Michel Cucherat, et al.
Thrombosis Research|April 12, 2011
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS)Alain Leizorovicz, Virginie Siguret, Dominique Mottier, et al.
Drugs & Aging|October 17, 2003
Aspirin for the prevention of cardiovascular events in the elderlyIsabelle Mahé, Alain Leizorovicz, Charles Caulin, et al.
Blood|September 2, 2011
The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legsPaolo Prandoni, Edoardo Casiglia, Valerie Tikhonoff, et al.
Blood|July 4, 2013
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO studyAlain Leizorovicz, François Becker, Andrea Buchmüller, et al.
Pageof 5